MSD’s investigational KRAS G12C inhibitor has shown signs of anti-tumour activity when used both alone and with other ...

Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...

Louisville MSD customers in Jefferson and Oldham counties could see higher prices starting in Summer 2025.

Daiichi Sankyo and MSD have voluntarily withdrawn the biologics licence application (BLA) in the US for their HER3-directed ...

Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the ...

The Louisville MSD Board approved a preliminary rate increase Tuesday, saying it's going to protect public health, property ...

A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...

He’s been putting more of his paycheck toward paying his MSD bill for the last 20 years. “They increase it every year it seems like,” Fawbush said. The company has raised rates every year since 2005.

AROUND 1,000 participants gathered before dawn on May 25, 2025, at Parqal Mall in Aseana City, Parañaque, to take part in the Run Against Cervical Cancer (RACC).